Northwest Biotherapeutics (NWBO) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free NWBO Stock Alerts $0.51 +0.01 (+2.00%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average of $0.67americanbankingnews.com - April 16 at 3:34 AMNorthwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directorsprnewswire.com - March 21 at 11:09 AM‘Spoofing’ case might draw back curtain on high-speed trading firmsft.com - March 2 at 10:11 AMNorthwest Biotherapeutics, Inc. (NWBO)uk.finance.yahoo.com - February 29 at 2:53 PMNorthwest Biotherapeutics Stock (OTC:NWBO), Short Interest Reportbenzinga.com - February 23 at 12:07 AMNorthwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certificationfinance.yahoo.com - February 7 at 4:37 PMNorthwest Biotherapeutics submits marketing application to UK MHRA for DCVax-Lmsn.com - December 22 at 10:28 AMNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For Glioblastomafinanznachrichten.de - December 21 at 12:53 PMNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastomafinance.yahoo.com - December 21 at 12:53 PMNorthwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Applicationfinance.yahoo.com - November 22 at 2:22 PMNorthwest Biotherapeutics Inc NWBOmorningstar.com - October 31 at 12:12 PMNorthwest Bio: Another Small Filing Delaymsn.com - October 14 at 10:44 AMNW Bio dips on announcing delay in submission of marketing application for DCVaxseekingalpha.com - October 13 at 12:56 PMNorthwest Biotherapeutics Shares Slide on Application Delaymarketwatch.com - October 13 at 12:56 PMNorthwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Applicationfinance.yahoo.com - October 13 at 12:56 PMNorthwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Boardfinance.yahoo.com - September 12 at 6:48 PMNorthwest Bio: Is There Ever Going To Be A Right Time?msn.com - August 17 at 9:29 PMNorthwest Missouri State Universityusnews.com - August 6 at 5:59 PMNorthwest Hospitalhealth.usnews.com - August 4 at 6:51 PMWhy Northwest Bio Is Shunned by Savvy Health Care Investorsthestreet.com - July 15 at 2:20 PMThree rounds of severe weather expected over the next 24 hours for Northwest Floridapnj.com - June 19 at 12:50 AMHCA Houston Healthcare Northwesthealth.usnews.com - June 13 at 11:38 PMNWBO - Northwest Biotherapeutics, Inc.finance.yahoo.com - May 27 at 11:04 AMNorthwest Bio Warns FDA May Throw Out Phase III Brain Cancer Studythestreet.com - May 9 at 5:00 PMNorthwest Medical Center-Tucsonhealth.usnews.com - April 13 at 7:37 AMNorthwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facilityfinance.yahoo.com - March 21 at 12:42 AMNorthwest Biotherapeutics Announces That It Has No Banking Relationship With SVBfinance.yahoo.com - March 11 at 8:39 PMNorthwest Bio in $11M loan agreement with Streeterville Capitalmsn.com - March 9 at 10:50 AMBrown-Lifespan researchers advance new vaccine to treat brain cancerbizjournals.com - January 6 at 3:58 PMNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023finance.yahoo.com - January 6 at 3:58 PMUS cancer drug company accuses market makers of stock spoofingft.com - December 1 at 7:07 PMCohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulationbenzinga.com - December 1 at 7:07 PMCancer drug company accuses US market makers of stock spoofingfinance.yahoo.com - December 1 at 7:07 PMNorthwest Biotherapeutics: Data Is Done, Just Wait For Approvalseekingalpha.com - November 23 at 9:33 AMNorthwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for Glioblastomafinance.yahoo.com - November 18 at 12:55 AMNorthwest Biotherapeutics: Biopharma's Promising Delinquentseekingalpha.com - October 18 at 8:59 AMUS Officials Seek Public Comment on Pacific Northwest Trailusnews.com - October 10 at 8:00 PMNWBO Northwest Biotherapeutics, Inc.seekingalpha.com - September 15 at 12:42 PMNorthwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRAfinance.yahoo.com - August 23 at 5:45 PMNorthwest Biotherapeutics: Q2 Earnings Snapshotapnews.com - August 10 at 4:02 PMNorthwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facilityfinance.yahoo.com - July 6 at 4:48 PMNorthwest Bio plunges after late-stage data for lead candidate in brain cancerseekingalpha.com - May 10 at 3:13 PMPresentation About Phase 3 Trial of DCVax®-L for Glioblastoma Today At New York Academy of Sciences To Be Available Online As Wellfinance.yahoo.com - May 10 at 3:13 PMNorthwest Biotherapeutics: Presentation About Phase 3 Trial of DCVax-L for Glioblastoma To Be Made At New York Academy Of Sciencesfinanznachrichten.de - May 5 at 9:17 PMPresentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciencesfinance.yahoo.com - May 4 at 1:25 PMNorthwest stock rises 9% as company begins cancer vaccine production at UK facilityseekingalpha.com - February 17 at 12:24 PMNorthwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facilityfinance.yahoo.com - February 17 at 12:24 PMDEDUCED RECKONING: Northwest Biotherapeutics receives license for Sawston UK plantnews.yahoo.com - December 30 at 7:28 AMNorthwest Biotherapeutics secures $15M financing on stock purchase rightsseekingalpha.com - December 5 at 8:32 PMNorthwest Biotherapeutics Announces $15 Million Financingfinance.yahoo.com - November 29 at 3:24 PM Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story NWBO Media Mentions By Week NWBO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWBO News Sentiment▼0.000.50▲Average Medical News Sentiment NWBO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWBO Articles This Week▼10▲NWBO Articles Average Week Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GRCL News ICVX News ARCT News HARP News ENTA News AKBA News ZVRA News VXRT News THRX News CYBN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWBO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.